会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MEANS AND METHODS FOR CONTROLLING COMMENSALES
    • 用于控制通信的手段和方法
    • WO2009103501A1
    • 2009-08-27
    • PCT/EP2009/001136
    • 2009-02-18
    • B.R.A.I.N.DECHERT, UteECK, JürgenKROHN, MichaelZEECK, Axel
    • DECHERT, UteECK, JürgenKROHN, MichaelZEECK, Axel
    • A61K8/49A61Q19/00A61P17/10
    • A61Q17/005A61K8/4973A61K8/498A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L31/16A61L2300/20A61L2300/404
    • This invention relates to a cosmetic composition comprising or consisting of one or more compounds selected from the compounds of formulae (A) and (B) wherein ---- represents a single bond or double bond; R 1 in formula (A) and R 1 in formula (B) are selected from H, linear or branched C 1 to C 4 alkyl, linear or branched C 1 to C 4 alkenyl, linear or branched C 1 to C 4 alkinyl, and linear or branched C 1 to C 4 alkanoyl; R 3 in formula (A) and R 3 in formula (B) are selected from H, linear or branched C 1 to C 4 alkyl, linear or branched C 1 to C 4 alkenyl, and linear or branched C 1 to C 4 alkinyl; R 2 and R 4 in formula (A) are independently selected from H, OH and halogen, or R 2 and R 4 together are O to form an epoxid, wherein ---- represents a single bond in case R 2 and R 4 together are O; and R 2 and R 4 in formula (B) are defined as R 2 and R 4 in formula (A), respectively. Preferably, said cosmetic composition is for the cleaning of the skin. Also provided are means and methods for the prevention or reduction of biofilm formation on an intracorporeal device and/or for the removal of biofilm from an intracorporeal device, wherein said biofilm comprises or consists of bacteria of the genus Propionibacterium . Furthermore provided is an intracorporeal device which is coated and/or loaded with one or more compounds as defined above.
    • 本发明涉及包含一种或多种选自式(A)和(B)的化合物的化合物或由其组成的化妆品组合物,其中----表示单键或双键; 式(A)中的R 1和式(B)中的R 1选自H,直链或支链C 1至C 4烷基,直链或支链C 1至C 4烯基,直链或支链C 1至C 4炔基,以及直链或支链C 1至C 4烷酰基 ; 式(A)中的R 3和式(B)中的R 3选自H,直链或支链C 1至C 4烷基,直链或支链C 1至C 4烯基,以及直链或支链C 1至C 4炔基; 式(A)中的R 2和R 4独立地选自H,OH和卤素,或者R 2和R 4一起为O以形成环氧化物,其中,在R 2和R 4一起为O的情况下,表示单键。 式(B)中的R 2和R 4分别定义为式(A)中的R 2和R 4。 优选地,所述化妆品组合物用于清洁皮肤。 还提供了用于预防或减少在体内装置上生物膜形成和/或从体内装置中除去生物膜的手段和方法,其中所述生物膜包含丙酸杆菌属的细菌或由其构成。 此外,提供了一种体外装置,其被涂覆和/或加载一种或多种如上所定义的化合物。
    • 2. 发明申请
    • MEANS AND METHODS FOR CONTROLLING COMMENSALES
    • 用于控制通信的手段和方法
    • WO2009103500A1
    • 2009-08-27
    • PCT/EP2009/001135
    • 2009-02-18
    • B.R.A.I.N.DECHERT, UteECK, Jürgen
    • DECHERT, UteECK, Jürgen
    • A61K8/35A61Q19/10A61P17/10A61Q19/00
    • A61K8/35A61L27/54A61L29/16A61L31/16A61L2300/404A61Q17/005
    • The present invention relates to a cosmetic composition for the cleaning of the skin, said composition comprising or consisting of one or more compounds of formula (I) wherein (formula II) represents a single bond or double bond; R 1 and R 2 are independently selected from H, linear or branched C 1 to C 4 alkyl, linear or branched C 1 to C 4 alkenyl, linear or branched C 1 to C 4 alkinyl, and linear or branched C 1 to C 4 alkanoyl; R 4 is selected from H, linear or branched C 1 to C 4 alkyl, linear or branched C 1 to C 4 alkenyl, and linear or branched C 1 to C 4 alkinyl; and R 3 and R 5 are independently selected from H, OH and halogen, or R 3 and R 5 together are O to form an epoxid, wherein (formula II) represents a single bond in case R 3 and R 5 together are O. Also provided are means and methods for the prevention or reduction of biofilm formation on an intracorporeal device and/or for the removal of biofilm from an intracorporeal device, wherein said biofilm comprises or consists of bacteria of the genus Propionibacterium. Furthermore provided is an intracorporeal device which is coated and/or loaded with one or more compounds as defined above.
    • 本发明涉及一种用于清洁皮肤的化妆品组合物,所述组合物包含一种或多种式(I)化合物或由其组成,其中(式II)表示单键或双键; R 1和R 2独立地选自H,直链或支链C 1至C 4烷基,直链或支链C 1至C 4烯基,直链或支链C 1至C 4炔基,和直链或支链C 1至C 4烷酰基; R4选自H,直链或支链C1至C4烷基,直链或支链C1至C4烯基,直链或支链C1至C4炔基; 并且R 3和R 5独立地选自H,OH和卤素,或者R 3和R 5一起为O以形成环氧化物,其中(式II)在情况R3和R5一起为O时表示单键。还提供了手段和方法 用于预防或减少在体内装置上生物膜形成和/或从体内装置中除去生物膜,其中所述生物膜包含丙酸杆菌属的细菌或由其构成。 此外,提供了一种体外装置,其被涂覆和/或加载一种或多种如上所定义的化合物。
    • 5. 发明申请
    • CHIMERIC SURFACE ACTIVE PROTEINS
    • CHIMERIC表面活性蛋白
    • WO2011101457A1
    • 2011-08-25
    • PCT/EP2011/052470
    • 2011-02-18
    • B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AGMEURER, GuidoGABOR, EstherBACHERT, AnkeECK, Jürgen
    • MEURER, GuidoGABOR, EstherBACHERT, AnkeECK, Jürgen
    • C07K14/37A61K47/42C09D189/00
    • C07K14/37A61K9/286A61K9/2873C09D189/00C12N15/62
    • The present invention relates to a nucleic acid molecule encoding a chimeric protein having the biochemical activity of a surface active protein, wherein said chimeric protein comprises: (a) an N-terminal portion of a first surface active protein, wherein the N-terminal portion is devoid of between 0 and 10 of the most N-terminal amino acids of the mature first surface active protein; and, C-terminally thereof, (b) a C-terminal portion of a second surface active protein, wherein the C-terminal portion is devoid of between 0 and 10 of the most C-terminal amino acids of the mature second surface active protein. The present invention further relates to a vector, a non-human host and a method for the production of a chimeric protein having the biochemical activity of a surface active protein. In addition, the present invention relates to a chimeric protein encoded by the nucleic acid molecule of the invention and a composition comprising the chimeric protein. The chimeric protein may only consist of the above mentioned core of (a) and (b), but may also be flanked by additional components of the core, i.e. (a) or (b) or by (an) additional complete core(s) (a) and (b). The present invention furthermore relates to a method of coating and/or impregnating a material, comprising contacting the material with the chimeric protein or the composition of the invention.
    • 本发明涉及编码具有表面活性蛋白的生化活性的嵌合蛋白的核酸分子,其中所述嵌合蛋白包含:(a)第一表面活性蛋白的N末端部分,其中所述N末端部分 没有成熟的第一表面活性蛋白的最多N末端氨基酸的0和10之间; 并且其C末端,(b)第二表面活性蛋白质的C末端部分,其中所述C末端部分缺少所述成熟第二表面活性蛋白质的最C末端氨基酸的0至10个 。 本发明还涉及载体,非人宿主和生产具有表面活性蛋白的生化活性的嵌合蛋白的方法。 此外,本发明涉及由本发明的核酸分子编码的嵌合蛋白质和包含该嵌合蛋白质的组合物。 嵌合蛋白质只能由上述(a)和(b)的核心组成,但也可以由核心的另外的组分,即(a)或(b)或另外一个完整的核心 )(a)和(b)。 本发明还涉及一种涂覆和/或浸渍材料的方法,包括使材料与本发明的嵌合蛋白或组合物接触。
    • 7. 发明申请
    • NOVEL MONOOXYGENASE VARIANTS
    • 新奥尔良的变化
    • WO2012028709A2
    • 2012-03-08
    • PCT/EP2011/065179
    • 2011-09-02
    • B.R.A.I.N. Biotechnology Research And Information Network AGSCHWANEBERG, UlrichBLANUSA, MilanNIEHAUS, FrankECK, Jürgen
    • SCHWANEBERG, UlrichBLANUSA, MilanNIEHAUS, FrankECK, Jürgen
    • C12N9/02
    • C12Y106/02004C12N9/0042
    • The present invention relates to a nucleic acid molecule encoding a polypeptide having cytochrome P450 monooxygenase activity, wherein said polypeptide comprises a reductase domain that deviates by at least one mutation from (a) the reductase domain of cytochrome P450 BM3, wherein the reductase domain of cytochrome P450 BM3 is represented by SEQ ID NO: 1; or (b) a reductase domain having at least 95% sequence identity to SEQ ID NO:1; and wherein said mutation(s) result(s) in an increased cytochrome P450 monooxygenase activity as compared to a polypeptide comprising the reductase domain of SEQ ID NO: 1. The present invention also relates to a vector comprising the nucleic acid molecule of the invention and a host transformed with the vector. Furthermore, the invention relates to a method of producing a polypeptide comprising culturing the host of the invention as well as to a polypeptide encoded by the nucleic acid molecule of the invention or produced by the method of the invention. The present invention further relates to the use of the polypeptide of the invention in biotransformation or fine chemical synthesis, to an oligo- or polynucleotide which specifically hybridizes to the nucleic acid molecule of the invention as well as to a composition and to a kit.
    • 本发明涉及编码具有细胞色素P450单加氧酶活性的多肽的核酸分子,其中所述多肽包含通过至少一个突变从(a)细胞色素P450 BM3的还原酶结构域偏移的还原酶结构域,其中细胞色素的还原酶结构域 P450 BM3由SEQ ID NO:1表示; 或(b)与SEQ ID NO:1具有至少95%序列同一性的还原酶结构域; 并且其中与包含SEQ ID NO:1的还原酶结构域的多肽相比,增加的细胞色素P450单加氧酶活性的所述突变结果。本发明还涉及包含本发明的核酸分子的载体 和一个用矢量转换的主机。 此外,本发明涉及产生多肽的方法,其包括培养本发明的宿主以及由本发明的核酸分子编码或通过本发明的方法生产的多肽。 本发明还涉及本发明的多肽在生物转化或精细化学合成中与本发明的核酸分子以及组合物和试剂盒特异性杂交的寡核苷酸或多核苷酸的用途。
    • 9. 发明申请
    • ARCHAEON EXPRESSION SYSTEM
    • ARCHAEON表达系统
    • WO2004106527A1
    • 2004-12-09
    • PCT/EP2004/005936
    • 2004-06-02
    • B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AGSCHLEPER, ChristaJONUSCHEIT, MelanieECK, JürgenNIEHAUS, FrankALBERS, Sonja-VerenaFROELS, Sabrina
    • SCHLEPER, ChristaJONUSCHEIT, MelanieECK, JürgenNIEHAUS, FrankALBERS, Sonja-VerenaFROELS, Sabrina
    • C12N15/74
    • C12N15/74
    • The present invention relates to a sulfolobus expression vector comprising: (a) sulfolobus origin of replication; (b) the genes encoding the structural proteins and the site-specific integrase of SSVI, SSV2 or pSSVx, operatively linked to expression control sequences and a packaging signal; (c) one or more selectable marker gene(s), operatively linked to sulfolobus expression control sequences; and (d) a sulfolobus promoter followed 3' by a restriction enzyme recognition site or a multiple cloning site for insertion of a gene of interest and optionally a 3' regulatory element. Moreover, the present invention relates to a shuttle vector comprising the sequences of the expression vector of the invention and additional sequences for propagation and selection in E. coli, wherein the additional sequences comprise (a) an E.coli on of replication; and (b) a marker for selection in E.coli. Furthermore, the invention relates to host cells transformed with the expression vector as well as to a kit comprising a vector or a host cell of the present invention. Finally, the present application also relates to a method for generating infectious subviral particles.
    • 本发明涉及一种磺基蛇毒表达载体,其包含:(a)磺基链复制起点; (b)编码与表达控制序列和包装信号有效连接的SSVI,SSV2或pSSVx的结构蛋白和位点特异性整合酶的基因; (c)一个或多个选择性标记基因,其可操作地连接到子叶表达控制序列; 和(d)通过限制性酶识别位点或用于插入目的基因和任选的3'调节元件的多克隆位点的3'后的磺基叶酸启动子。 此外,本发明涉及包含本发明的表达载体的序列和在大肠杆菌中用于繁殖和选择的其它序列的穿梭载体,其中所述另外的序列包含(a)复制的大肠杆菌; 和(b)在大肠杆菌中选择的标记物。 此外,本发明涉及用表达载体转化的宿主细胞以及包含本发明的载体或宿主细胞的试剂盒。 最后,本申请还涉及产生感染性亚病毒颗粒的方法。